|
HS Code |
854712 |
As an accredited 6-Bromo-2,4-Dichloroquinazoline factory, we enforce strict quality protocols—every batch undergoes rigorous testing to ensure consistent efficacy and safety standards.
| Packing | |
| Shipping | |
| Storage |
Competitive 6-Bromo-2,4-Dichloroquinazoline prices that fit your budget—flexible terms and customized quotes for every order.
For samples, pricing, or more information, please call us at +8615371019725 or mail to admin@sinochem-nanjing.com.
We will respond to you as soon as possible.
Tel: +8615371019725
Email: admin@sinochem-nanjing.com
Flexible payment, competitive price, premium service - Inquire now!
Every once in a while, a compound shows up in labs that shifts the way research moves forward. 6-Bromo-2,4-Dichloroquinazoline finds its way into this category, offering a rare balance between structural complexity and functional adaptability. In my years watching the chemical industry grow, I've seen how new building blocks can open or close doors to entire classes of drugs, dyes, or materials. The molecular framework of this compound—marked by its quinazoline ring, bromine at position six, and two chlorines at positions two and four—delivers more than textbook novelty. It brings tangible options for synthesis that other intermediates struggle to match.
Quinazoline derivatives have long caught the attention of scientists. Their core skeleton underpins many pharmaceutical agents, agrochemicals, and even certain advanced materials. The twin chlorines and lone bromine on this structure don’t just look good on paper; they create real reaction handles. In practice, this means more choices in downstream modification, particularly for Suzuki or Buchwald–Hartwig couplings—a fact many chemists respect because fewer steps result in fewer headaches and reduced waste.
From my perspective, the availability of a compound like 6-Bromo-2,4-Dichloroquinazoline signals progress for organizations looking to skip archaic multi-step syntheses. During my time collaborating with medicinal chemistry teams, I saw their frustration when a key intermediate called for a lengthy workaround. This product, with its reactive sites and manageable molecular weight, saves weeks of labor. The bromine comes off cleanly in palladium-catalyzed reactions, while the chlorines offer potent options for further functionalization, especially for complex heterocyclic transformations.
6-Bromo-2,4-Dichloroquinazoline walks a fine line: it stands robust during shipping and storage, yet offers the kind of reactivity demanded by swift, efficient synthesis routes. As a white to off-white crystalline powder, its physical form eases handling and weighing for most routine lab procedures. With a molecular formula of C8H3BrCl2N2 and a molar mass around 293.94 g/mol, the compound presents itself as straightforward to measure and scale.
Most chemists seek purity above 98%, and this compound typically clears that bar when sourced from reputable suppliers. Low moisture content assures better stability, reducing degradation risk during storage or transport. Aromatic halides, especially with multiple substitutions, can be tricky to manufacture at scale, but producers with advanced purification technology deliver batches with consistent color, melting point, and impurity profiles. In the real world, that means fewer surprises down the line—nobody wants to redo weeks of work after spotting a contaminant in their NMR spectra.
Usage patterns for 6-Bromo-2,4-Dichloroquinazoline differ depending on the field, but a few themes surface no matter where you look. In my time working around process chemistry, I've seen this material used mainly as an intermediate for crafting more elaborate molecules. Drug discovery teams have employed it in the construction of kinase inhibitors or other active pharmaceutical ingredients (APIs). Its modular reactivity appeals to those optimizing lead compounds: the bromine often gets swapped out in a Suzuki coupling, while the chlorines await selective substitution.
Crop science and agrochemical firms look for stable starting points to build libraries of candidates targeting pests or weeds. Modifying the quinazoline core produces analogues with variable physical and biological profiles. Because 6-Bromo-2,4-Dichloroquinazoline can be readily decorated at multiple positions, it’s suited for high-throughput discovery—where dozens or even hundreds of variations are synthesized and tested for activity. The fewer bottlenecks in this early phase, the quicker promising compounds emerge.
Specialty chemicals and polymers sometimes draw on quinazoline derivatives for unique physical or electrical behavior, making this compound a potential component for advanced material science. Anyone involved in custom synthesis will appreciate the flexibility, as each halogen acts as an invitation for further chemical creativity.
Looking at 6-Bromo-2,4-Dichloroquinazoline in the context of comparable compounds—such as its mono-chlorinated relatives or non-halogenated analogs—reveals a few important distinctions. The dual chlorine and single bromine substitution patterns enable sequential or selective reactions, avoiding troublesome mixtures of isomers. A chemist hoping to introduce a variety of side chains or heteroatoms finds more freedom compared to starting material with less predictable substitution outcomes.
In a world where batches run into kilograms or beyond, ease of purification gains importance. Many aromatic halides undergo unwanted side-reactions, especially under the heat and chemical load of upscaling. This compound’s resilience in standard storage and handling lessens risk, enabling smoother translation from milligram test reactions to pilot plant runs.
Having worked alongside bench chemists, I know the difference between theory and lived experience: some vials collect dust because their behavior doesn’t match the literature. 6-Bromo-2,4-Dichloroquinazoline rarely falls into this trap because its reactivity matches expectations, cutting down frustration and saving research budgets from being wasted on “problem” intermediates.
Lab professionals, regulatory managers, and procurement teams all look for consistency and compliance. Traceability of batches, certified purity profiles, and an established safety record build confidence for those responsible for final products, whether in pharma, agriculture, or materials. During my visits to manufacturing sites, it became clear that this compound ships stably and packs according to industry-standard guidelines for hazardous goods—protecting workers and facilities from unwanted incidents.
While all chemicals should be respected as potential hazards, 6-Bromo-2,4-Dichloroquinazoline doesn’t present complications beyond those usually encountered in its functional group class. Following accepted handling protocols, using proper PPE, and employing fume hoods safeguard health and property. Regular analytical testing keeps the process on track, alerting teams early if any batch falls short of promised specs. With the increasing focus on trace contaminants and green chemistry, living up to high standards earns trust, especially where environmental impact and end-user safety are headline concerns.
Beyond its present uses, this compound quietly surfaces in research papers exploring next-generation therapies. Medicinal chemistry journals describe new inhibitors, anti-infectives, or anti-cancer agents built from quinazoline scaffolds. Its halogen pattern makes it a trusted platform for structure-activity relationship studies, as changing out one site at a time produces valuable biological data. Open-access publications and patent filings frequently reference 6-Bromo-2,4-Dichloroquinazoline by name, tying it to discoveries that could shape future treatment options.
I’ve seen industry go through phases: chasing blockbuster drugs, pivoting toward targeted small molecules, and now navigating complicated biologics and personalized medicine. Simple intermediates like this compound never lose their importance. Because automation and machine-learning tools expand the range of what labs can screen, having a reliable, multi-site modified scaffold like this one ensures the pace of discovery stays up. Where time and reproducibility count most, choosing strong intermediates is half the battle.
For procurement teams and researchers alike, access to specialty intermediates often makes or breaks a project’s timeline. In my work supporting R&D efforts, delays often trace back to suppliers struggling to ship pure material on schedule. Reliable supply chains for compounds like 6-Bromo-2,4-Dichloroquinazoline offer peace of mind, especially when projects rely on steady progress and quick turnaround. The commercial market for this compound remains healthy, with reputable vendors listing it in research and semi-bulk portions—typically from grams to multi-kilogram lots.
Regarding cost, the halogenated nature of the molecule translates to moderate expense, especially when compared to less functionalized quinazolines. The savings come downstream; with fewer reaction steps and less need to troubleshoot poorly-behaved intermediates, total project budgets land in a more comfortable zone. Cost-sensitive markets, such as agricultural chemicals or generic pharmaceuticals, particularly value intermediates that don’t surprise with hidden process snags or quality variability. Vendors accepting long-term supply agreements—sometimes even custom contract manufacturing—create stability, letting R&D teams plan larger campaigns with less risk of last-minute product shortfalls.
The chemical industry faces ongoing scrutiny around sustainability and ethical responsibility. Halogenated aromatic compounds sometimes spark debate regarding their persistence in the environment, so care with waste streams and emission controls remains vital. Responsible producers invest in waste treatment technology, reducing the risk of accidental release. Laboratories increasingly factor in life-cycle analysis for chemicals like 6-Bromo-2,4-Dichloroquinazoline, aiming to balance research needs with a conscious effort to limit environmental impact.
Green chemistry pushes everyone to rethink established protocols. Chemists adapting these principles might look for cleaner coupling reactions, solvent recovery, and ways to minimize generations of halogenated byproducts during both lab and production activities. By prioritizing high-purity, predictable material, teams minimize wasted reagents and energy—both important steps toward sustainability. As governments raise the bar on regulation, robust quality and safety documentation build further trust, not only with clients, but also with oversight agencies focused on human health and ecology.
Projects in discovery chemistry or materials science hit rough patches for plenty of reasons, but having strong starting materials should not be the bottleneck. From my years of troubleshooting problems in the lab, one fact stands out: a reliable intermediate like 6-Bromo-2,4-Dichloroquinazoline can transform the scope and speed of R&D. For teams weighing different options, transparency in analytical data and dependable logistics matter a lot. Choosing vendors known for clear documentation and batch repeatability sidesteps delays from out-of-spec material.
For organizations looking to get more from their research, investing in staff training around modern halogen-substituted aromatic chemistry delivers returns. Sophisticated analytical labs—NMR, HPLC, mass spectrometry—catch issues early and validate supplier claims, keeping projects on track. Collaboration among academic, commercial, and government partners promotes improvements in synthesis, environmental management, and responsible market practices.
Many challenges facing today’s chemical industry—supply chain disruption, increased regulatory pressure, tightened budgets—find partial answers in solid tools like 6-Bromo-2,4-Dichloroquinazoline. Experienced scientists know that one versatile intermediate solves problems before they even start: sidestepping extra purification, shortening synthesis timelines, and opening the door to otherwise out-of-reach analogs. The future will continue to reward teams who select their building blocks wisely, placing trust in compounds shaped by decades of development and adaptation.
Few things matter more in chemical research than the tools chosen for the job. Through its versatility, purity, and performance, 6-Bromo-2,4-Dichloroquinazoline supports innovations in drug discovery, crop protection, and materials science. Chemists value intermediates that make tough projects more manageable, and this compound earns its spot on the top shelf of many labs. By bridging practicality and reliability, it stands ready not only for today’s research challenges, but also for the evolving demands of science and industry tomorrow.